| Antithrombotic therapy in the coronary vein graft patient. | |
| | |
MedLine Citation:
|
PMID: 2032405 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Coronary artery bypass grafting is an important therapeutic modality in the treatment of the patient with coronary artery disease; however, long-term results are limited by the development of saphenous vein graft disease early and late after operation. The pathogenesis of early vein graft occlusion is primarily thrombotic, while that occurring later frequently involves thrombosis superimposed on intimal hyperplasia or vein graft atherosclerosis. We describe the role of various platelet inhibitors and anticoagulants in the prevention of saphenous vein graft occlusion following coronary artery bypass grafting. |
| | |
Authors:
|
D H Israel; P C Adams; B Stein; J H Chesebro; V Fuster |
Related Documents
:
|
7873735 - Mismatch in elastic properties around anastomoses of interposition grafts for hemodialy... 12368725 - Predicting iliac limb occlusions after bifurcated aortic stent grafting: anatomic and d... 15971145 - Nerve repair using a vein graft filled with collagen gel. 3729715 - A five-year experience with the bovine heterograft for vascular access. 17384955 - Association of cervical internal carotid artery aneurysm with ipsilateral vertebrobasil... 23171085 - Bidirectional asynchronous arterial flow in monochorionic twins - a precursor to the tw... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinical cardiology Volume: 14 ISSN: 0160-9289 ISO Abbreviation: Clin Cardiol Publication Date: 1991 Apr |
Date Detail:
|
Created Date: 1991-06-26 Completed Date: 1991-06-26 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 7903272 Medline TA: Clin Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 283-95 Citation Subset: IM |
Affiliation:
|
Division of Cardiology, Mount Sinai School of Medicine, New York, NY 10029. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Coronary Artery Bypass* Fibrinolytic Agents / pharmacology, therapeutic use* Graft Occlusion, Vascular / physiopathology, prevention & control* Humans Saphenous Vein / transplantation Thrombolytic Therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety.
Next Document: Long-term clinical course of patients with angina and angiographically normal coronary arteries.